These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2137936)

  • 1. Na+1-activated and ATP-sensitive K+ channels in the heart.
    Sanguinetti MC
    Prog Clin Biol Res; 1990; 334():85-109. PubMed ID: 2137936
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphonylurea drugs no longer inhibit ATP-sensitive K+ channels during metabolic stress in cardiac muscle.
    Findlay I
    J Pharmacol Exp Ther; 1993 Jul; 266(1):456-67. PubMed ID: 8331572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
    Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
    Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of ATP-sensitive K+ channel activity and contractile behavior in mammalian ventricle by the potassium channel openers cromakalim and RP49356.
    Ripoll C; Lederer WJ; Nichols CG
    J Pharmacol Exp Ther; 1990 Nov; 255(2):429-35. PubMed ID: 2243335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRL 34915 (cromakalim) activates ATP-sensitive K+ current in cardiac muscle.
    Sanguinetti MC; Scott AL; Zingaro GJ; Siegl PK
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8360-4. PubMed ID: 2460868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External ATP antagonizes the effect of potassium channel openers in guinea-pig ventricular papillary muscle.
    Bott A; Eltze M; Illes P
    Eur J Pharmacol; 1992 Mar; 213(1):141-4. PubMed ID: 1499650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of K-channel openers on the contractility and electrical activity of antral circular muscle in guinea-pig stomach.
    Kim KW; Kim SJ; Jun JY
    J Smooth Muscle Res; 1993 Oct; 29(5):145. PubMed ID: 8167416
    [No Abstract]   [Full Text] [Related]  

  • 9. K+ channel-opening properties of a novel compound, NIP-121, in guinea pig myocardium as compared with those of cromakalim.
    Matsuda T; Okazaki K; Kato Y; Tanaka H; Shigenobu K
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):608-13. PubMed ID: 8569223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical and energetic effects of cromakalim on guinea pig left ventricular papillary muscle.
    Joseph T; Coirault C; Ducros L; Lecarpentier Y
    J Pharmacol Exp Ther; 1996 Nov; 279(2):464-71. PubMed ID: 8930147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
    Venkatesh N; Stuart JS; Lamp ST; Alexander LD; Weiss JN
    Circ Res; 1992 Dec; 71(6):1324-33. PubMed ID: 1423930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning.
    Shigematsu S; Sato T; Abe T; Saikawa T; Sakata T; Arita M
    Circulation; 1995 Oct; 92(8):2266-75. PubMed ID: 7554211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
    Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
    Grover GJ
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S18-27. PubMed ID: 7898104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
    Nakaya H
    Kokyu To Junkan; 1993 Jun; 41(6):512-20. PubMed ID: 8337509
    [No Abstract]   [Full Text] [Related]  

  • 16. HOE-234, a second generation K+ channel opener, antagonizes the ATP-dependent gating of cardiac ATP-sensitive K+ channels.
    Terzic A; Jahangir A; Kurachi Y
    J Pharmacol Exp Ther; 1994 Feb; 268(2):818-25. PubMed ID: 8113994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ATP-sensitive K+ channel blockers on the action potential shortening in hypoxic and ischaemic myocardium.
    Nakaya H; Takeda Y; Tohse N; Kanno M
    Br J Pharmacol; 1991 May; 103(1):1019-26. PubMed ID: 1908730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A; Szerdahelyi P; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanosine diphosphate is required for activation of a glyburide, ATP and cromakalim-sensitive outward current in rat hippocampal neurones.
    Erdemli G; Krnjević K
    Neuroreport; 1994 Jun; 5(11):1362-4. PubMed ID: 7919200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of SR 44866, a potassium channel opener, on action potentials of rabbit, guinea pig, and human heart fibers.
    Gautier P; Bertrand JP; Guiraudou P
    J Cardiovasc Pharmacol; 1991 May; 17(5):692-700. PubMed ID: 1713982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.